Sponsor Pipeline

GenomeFrontier Therapeutics TW Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06703892 A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell)… Diffuse Large B Cell Lymphoma Relapsed Recruiting
Not specified
NCT06985576 Long-term Study to Evaluate Safety and Persistence of GF-CART01 DLBCL - Diffuse Large B Cell Lymphoma Enrolling by Invitation
Disease Areas
Follicular Lymphoma (2) DLBCL (1)
Get alerts when GenomeFrontier Therapeutics TW Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free